SELVAS Healthcare 2025 Business Report: Operating Loss but Net Income Up

Consolidated revenue for 12th fiscal year (2025): KRW 30.8 billion, operating loss of KRW 1.6 billion (vs operating profit of KRW 3.3 billion previous year)
Net income: KRW 3.9 billion (up 23% from KRW 3.2 billion, including KRW 4.7 billion gain from financial assets)
Parent company: revenue KRW 28.8 billion, operating loss KRW 0.6 billion, net income KRW 4.1 billion
Total assets KRW 79 billion, debt ratio 11.06% (previous 10.07%), net cash KRW 8.3 billion
Revaluation surplus increased by KRW 3.5 billion from land and building revaluation
R&D expenses KRW 4 billion (13.07% of revenue), new product launches and AI integration
Acquired convertible note of Evolt Holdings for AUD 5 million in Jan 2026
No dividends, no shareholder return policy